Magnesium Sulfate Reduces Carrageenan-Induced Rat Paw Inflammatory Edema Via Nitric Oxide Production

Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. Methods In a rat model of carrageenan-induced paw inflammation, the...

Full description

Saved in:
Bibliographic Details
Published in:Dose-response Vol. 21; no. 1; p. 15593258231155788
Main Authors: Srebro, Dragana, Dožić, Branko, Savić Vujović, Katarina, Medić Brkić, Branislava, Vučković, Sonja
Format: Journal Article
Language:English
Published: Los Angeles, CA SAGE Publications 01-01-2023
SAGE PUBLICATIONS, INC
SAGE Publishing
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. Methods In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. Results MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS. Conclusions Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide.
AbstractList BackgroundMagnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. MethodsIn a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. ResultsMS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS. ConclusionsMagnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide.
Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. Methods In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. Results MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS. Conclusions Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide.
Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. Methods In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. Results MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS. Conclusions Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide.
Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, < .05) and 55% (30 mg/kg, < .05). MS administered locally (.5 mg/paw, < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, < .05) or reduced (3 mg/kg, < .05), while in the highest tested dose L-NPA (2 mg/kg, < .01) and SMT (.015 mg/kg, < .01) reduced the anti-edematous effect of MS. Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide.
Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in different protocols of use and the possible mechanism of its action. Methods In a rat model of carrageenan-induced paw inflammation, the anti-edematous activity of MS was assessed with a plethysmometer. The effects of the nonselective inhibitor (L-NAME), selective inhibitor of neuronal (L-NPA) and inducible (SMT) nitric oxide synthase on the effects of MS were evaluated. Results MS administered systemically before or after inflammation reduced edema by 30% (5 mg/kg, P < .05) and 55% (30 mg/kg, P < .05). MS administered locally (.5 mg/paw, P < .05) significantly prevented the development of inflammatory edema by 60%. L-NAME, intraperitoneally administered before MS, potentiated (5 mg/kg, P < .05) or reduced (3 mg/kg, P < .05), while in the highest tested dose L-NPA (2 mg/kg, P < .01) and SMT (.015 mg/kg, P < .01) reduced the anti-edematous effect of MS. Conclusions Magnesium is a more effective anti-edematous drug in therapy than for preventing inflammatory edema. The effect of MS is achieved after systemic and local peripheral administration and when MS is administered as a single drug in a single dose. This effect is mediated at least in part via the production of nitric oxide.
Author Savić Vujović, Katarina
Srebro, Dragana
Dožić, Branko
Vučković, Sonja
Medić Brkić, Branislava
Author_xml – sequence: 1
  givenname: Dragana
  orcidid: 0000-0002-9680-0840
  surname: Srebro
  fullname: Srebro, Dragana
  email: srebrodragana1@gmail.com
  organization: Department of Pathology, School of Dental Medicine
– sequence: 2
  givenname: Branko
  surname: Dožić
  fullname: Dožić, Branko
  organization: Department of Pathology, School of Dental Medicine
– sequence: 3
  givenname: Katarina
  orcidid: 0000-0002-4701-6291
  surname: Savić Vujović
  fullname: Savić Vujović, Katarina
  organization: Department of Pathology, School of Dental Medicine
– sequence: 4
  givenname: Branislava
  orcidid: 0000-0001-7012-6766
  surname: Medić Brkić
  fullname: Medić Brkić, Branislava
  organization: Department of Pathology, School of Dental Medicine
– sequence: 5
  givenname: Sonja
  surname: Vučković
  fullname: Vučković, Sonja
  organization: Department of Pathology, School of Dental Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36756149$$D View this record in MEDLINE/PubMed
BookMark eNp1kktv1DAUhSNURB_wA9ggS2zYTPEzjjdIaFTKSIVW5bG1buObwaPEbu0E2n-Pw5TSglj56vicz7723a92QgxYVc8ZPWRM69dMKSO4arhgpdRN86jam7XFLO7cq3er_Zw3lEqlBXtS7Ypaq5pJs1e5D7AOmP00kE9T38GI5Bzd1GImS0gJ1ogBwmIVZs2RcxjJGfwgq9D1MAwwxnRDjhwOQL56IB_9mHxLTq-9Q3KWYgmNPoan1eMO-ozPbteD6su7o8_L94uT0-PV8u3JolWCjwvDHG1KR7rjVGp9ITtpBHXOdbVCozvHtTESmQJoqXHIGi4FItaNVsYxKQ6q1ZbrImzsZfIDpBsbwdtfQkxrC2n0bY-W1y2IhjeArJVtydPOKM7A1YLxuuOF9WbLupwuBnQthjFB_wD6cCf4b3Ydv1tjKK31DHh1C0jxasI82sHnFvseAsYpW661bIyWzBTry7-smzilUJ6quAxvBJNqBrKtq00x54Td3WUYtfM82H_moWRe3O_iLvF7AIrhcGvI5av_HPt_4k8Ptr5d
CitedBy_id crossref_primary_10_1016_j_niox_2024_02_005
crossref_primary_10_1016_j_jep_2024_118216
crossref_primary_10_3390_ijms24076241
Cites_doi 10.1371/journal.pone.0135558
10.1096/fasebj.7.13.8405815
10.1016/j.ejphar.2018.07.022
10.1684/mrh.2014.0364
10.1007/s10787-017-0361-0
10.1016/j.neuroscience.2016.09.032
10.1016/S0006-8993(01)03240-1
10.1007/BF02024731
10.1038/srep00380
10.1007/BF00178952
10.1016/S0024-3205(02)02371-8
10.1007/s10787-018-0526-5
10.5812/aapm.16316
10.1007/s11011-019-00419-y
10.1248/bpb.30.1934
10.1177/15593258221103846
10.1111/j.1476-5381.1971.tb07124.x
10.3389/neuro.01.024.2009
10.1007/BF01993127
10.1016/S0014-2999(03)01604-2
10.3109/13880209.2014.996821
10.1038/nature01320
10.1161/01.HYP.0000146536.68208.84
10.4049/jimmunol.166.2.1169
10.3390/nu14030679
10.1016/S0006-8993(01)02733-0
10.1016/j.physbeh.2014.11.042
10.2174/0929867323666161213101744
10.3389/fmed.2022.923282
10.1186/ar2208
10.1016/j.abb.2006.03.031
10.1017/S0007114510003107
10.1016/j.pharep.2017.08.005
10.1016/0304-3959(95)00113-1
10.1016/S0014-2999(02)02119-2
ContentType Journal Article
Copyright The Author(s) 2023
The Author(s) 2023.
The Author(s) 2023. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2023 2023 SAGE Publications
Copyright_xml – notice: The Author(s) 2023
– notice: The Author(s) 2023.
– notice: The Author(s) 2023. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2023 2023 SAGE Publications
DBID AFRWT
NPM
AAYXX
CITATION
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1177/15593258231155788
DatabaseName Sage Journals GOLD Open Access 2024
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

PubMed

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 1559-3258
EndPage 15593258231155788
ExternalDocumentID oai_doaj_org_article_26ca3828ae1c4c7590f9521ad63126f2
10_1177_15593258231155788
36756149
10.1177_15593258231155788
Genre Journal Article
GrantInformation_xml – fundername: The Ministry of Education and Science of the Republic of Serbia
  grantid: Grant No. 200110
– fundername: ;
  grantid: Grant No. 200110
GroupedDBID ---
0R~
29G
2WC
31X
53G
54M
5GY
5VS
7X7
8FI
8FJ
AAFWJ
AAJPV
AAJQC
AAKDD
AAQQG
AATBZ
ABAWP
ABDBF
ABJIS
ABNCE
ABQXT
ABUWG
ABVFX
ABXGC
ACARO
ACDXX
ACGFS
ACGZU
ACROE
ACSIQ
ADBBV
ADOGD
AENEX
AEUHG
AEUIJ
AEWDL
AEWHI
AFCOW
AFKRA
AFKRG
AFPKN
AFRWT
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ARTOV
AUTPY
AYAKG
B0M
BAWUL
BCNDV
BDDNI
BENPR
BPHCQ
BSEHC
BVXVI
CCPQU
CS3
DC.
DIK
DU5
DV7
E3Z
EAP
EBD
EBS
EDH
EMK
ESX
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
HMCUK
HYE
J8X
K.F
KQ8
M4V
MET
MK0
M~E
O9-
OK1
PIMPY
PQQKQ
ROL
RPM
SFC
SFK
SFT
SGV
SPP
TR2
TUS
UKHRP
~8M
4.4
EJD
H13
IPNFZ
NPM
RIG
AAYXX
CITATION
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c532t-91d085937f20477b4f4930dddf65e97fd27994e15aac09de18243eee68759d143
IEDL.DBID RPM
ISSN 1559-3258
IngestDate Tue Oct 22 14:53:30 EDT 2024
Tue Sep 17 21:30:31 EDT 2024
Fri Oct 25 00:41:59 EDT 2024
Thu Oct 10 20:09:42 EDT 2024
Wed Oct 09 16:47:29 EDT 2024
Sat Sep 28 08:22:14 EDT 2024
Tue Jul 16 20:39:07 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords preemptive therapy
anti-inflammatory
emptive therapy
magnesium
anti-edematous
NOS inhibitors
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
The Author(s) 2023.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c532t-91d085937f20477b4f4930dddf65e97fd27994e15aac09de18243eee68759d143
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-9680-0840
0000-0001-7012-6766
0000-0002-4701-6291
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900672/
PMID 36756149
PQID 2792831452
PQPubID 4450826
ParticipantIDs doaj_primary_oai_doaj_org_article_26ca3828ae1c4c7590f9521ad63126f2
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9900672
proquest_miscellaneous_2774897419
proquest_journals_2792831452
crossref_primary_10_1177_15593258231155788
pubmed_primary_36756149
sage_journals_10_1177_15593258231155788
PublicationCentury 2000
PublicationDate 2023-01-01
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Los Angeles, CA
PublicationPlace_xml – name: Los Angeles, CA
– name: United States
– name: Thousand Oaks
– name: Sage CA: Los Angeles, CA
PublicationTitle Dose-response
PublicationTitleAlternate Dose Response
PublicationYear 2023
Publisher SAGE Publications
SAGE PUBLICATIONS, INC
SAGE Publishing
Publisher_xml – name: SAGE Publications
– name: SAGE PUBLICATIONS, INC
– name: SAGE Publishing
References Fujii, Irie, Uchida, Tsukahara, Muraki 1994; 350
Morris 2003; 225
Shadman, Sadeghian, Moradi, Bohlooli, Panahpour 2019; 34
Gupta, Parasar, Sagar 2015; 10
Aryana, Rajaei, Bagheri, Karimi, Dabbagh 2014; 4
Masini, Salvemini, Pistelli, Mannaioni, Vane 1991; 33
Infante, Díaz, Hernández, Constandil, Pelissier 2007; 9
Nathan 2002; 420
Srebro, Vučković, Vujović, Prostran 2014; 27
Vuckovic, Srebro, Savic Vujovic, Prostran 2015; 53
Freire, Guimarães, Leal, Pereira 2009; 3
Crunkhorn, Meacock 1971; 42
Mazur, Maier, Rock, Gueux, Nowacki, Rayssiguier 2007; 458
Oliveira, de Almeida, de Oliveira 2018; 834
Veronese, Pizzol, Smith, Dominguez, Barbagallo 2022; 14
Yokoyama, Oono, Miyamoto, Ishiguro, Nishio 2003; 72
Otterness, Wiseman, Gans 1979; 9
Shimosawa, Takano, Ando, Fujita 2004; 44
Srebro, Vučković, Savić Vujović, Prostran 2015; 139
Xiang, Ji, Jiang, Huang, Yan 2022; 9
Paul-Clark, Gilroy, Willis, Willoughby, Tomlinson 2001; 166
Tandoh, Danquah, Benneh, Adongo, Boakye-Gyasi, Woode 2022; 20
Zanchet, Cury 2003; 467
Sawynok, Reid 2002; 450
Felsby, Nielsen, Arendt-Nielsen, Jensen 1996; 64
Srebro, Vuckovic, Milovanovic, Kosutic, Vujovic, Prostran 2017; 24
Omote, Hazama, Kawamata 2001; 912
Kubes, Kanwar, Niu, Gaboury 1993; 7
Nagai, Fukuhata, Ito, Tai, Hataguchi, Nakagawa 2007; 30
Srebro, Vučković, Dožić 2018; 70
Moilanen, Laavola, Kukkonen 2012; 2
Guiet-Bara, Durlach, Bara 2007; 20
Srebro, Vučković, Milovanović, Vujović, Vučetić, Prostran 2019; 27
Srebro, Vučković, Prostran 2016; 339
Jarosz, Szkaradek, Marona, Nowak, Młyniec, Librowski 2017; 25
Beirith, Santos, Calixto 2002; 924
Odabasoglu, Halici, Aygun 2011; 105
bibr26-15593258231155788
bibr36-15593258231155788
bibr8-15593258231155788
bibr3-15593258231155788
bibr30-15593258231155788
bibr29-15593258231155788
bibr19-15593258231155788
bibr6-15593258231155788
bibr10-15593258231155788
bibr16-15593258231155788
bibr33-15593258231155788
bibr20-15593258231155788
bibr23-15593258231155788
bibr13-15593258231155788
bibr21-15593258231155788
bibr31-15593258231155788
bibr34-15593258231155788
bibr11-15593258231155788
bibr14-15593258231155788
bibr27-15593258231155788
bibr24-15593258231155788
bibr17-15593258231155788
bibr37-15593258231155788
bibr4-15593258231155788
bibr7-15593258231155788
bibr32-15593258231155788
bibr1-15593258231155788
bibr28-15593258231155788
bibr2-15593258231155788
bibr9-15593258231155788
bibr5-15593258231155788
bibr15-15593258231155788
bibr25-15593258231155788
bibr35-15593258231155788
bibr22-15593258231155788
Morris C (bibr18-15593258231155788) 2003; 225
Guiet-Bara A (bibr12-15593258231155788) 2007; 20
References_xml – volume: 2
  start-page: 380
  year: 2012
  article-title: TRPA1 contributes to the acute inflammatory response and mediates carrageenan-induced paw edema in the mouse
  publication-title: Sci Rep
  contributor:
    fullname: Kukkonen
– volume: 3
  start-page: 175
  issue: 2
  year: 2009
  end-page: 181
  article-title: Pain modulation by nitric oxide in the spinal cord
  publication-title: Front Neurosci
  contributor:
    fullname: Pereira
– volume: 33
  start-page: 61
  issue: 1-2
  year: 1991
  end-page: 63
  article-title: Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine
  publication-title: Agents Actions
  contributor:
    fullname: Vane
– volume: 225
  start-page: 115
  year: 2003
  end-page: 121
  article-title: Carrageenan-induced paw edema in the rat and mouse
  publication-title: Methods Mol Biol
  contributor:
    fullname: Morris
– volume: 139
  start-page: 267
  year: 2015
  end-page: 273
  article-title: TRPA1, NMDA receptors and nitric oxide mediate mechanical hyperalgesia induced by local injection of magnesium sulfate into the rat hind paw
  publication-title: Physiol Behav
  contributor:
    fullname: Prostran
– volume: 25
  start-page: 653
  issue: 6
  year: 2017
  end-page: 663
  article-title: Evaluation of anti-inflammatory and ulcerogenic potential of zinc-ibuprofen and zinc-naproxen complexes in rats
  publication-title: Inflammopharmacology
  contributor:
    fullname: Librowski
– volume: 30
  start-page: 1934
  issue: 10
  year: 2007
  end-page: 1937
  article-title: Preventive effect of water containing magnesium ion on paw edema in adjuvant-induced arthritis rat
  publication-title: Biol Pharm Bull
  contributor:
    fullname: Nakagawa
– volume: 64
  start-page: 283
  issue: 2
  year: 1996
  end-page: 291
  article-title: NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride
  publication-title: Pain
  contributor:
    fullname: Jensen
– volume: 70
  start-page: 81
  issue: 1
  year: 2018
  end-page: 86
  article-title: Magnesium sulfate reduces formalin-induced orofacial pain in rats with normal magnesium serum levels
  publication-title: Pharmacol Rep
  contributor:
    fullname: Dožić
– volume: 924
  start-page: 219
  issue: 2
  year: 2002
  end-page: 228
  article-title: Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw
  publication-title: Brain Res
  contributor:
    fullname: Calixto
– volume: 912
  start-page: 171
  issue: 2
  year: 2001
  end-page: 175
  article-title: Peripheral nitric oxide in carrageenan-induced inflammation
  publication-title: Brain Res
  contributor:
    fullname: Kawamata
– volume: 458
  start-page: 48
  issue: 1
  year: 2007
  end-page: 56
  article-title: Magnesium and the inflammatory response: Potential physiopathological implications
  publication-title: Arch Biochem Biophys
  contributor:
    fullname: Rayssiguier
– volume: 34
  start-page: 1221
  issue: 4
  year: 2019
  end-page: 1229
  article-title: Magnesium sulfate protects blood-brain barrier integrity and reduces brain edema after acute ischemic stroke in rats
  publication-title: Metab Brain Dis
  contributor:
    fullname: Panahpour
– volume: 166
  start-page: 1169
  issue: 2
  year: 2001
  end-page: 1177
  article-title: Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration
  publication-title: J Immunol
  contributor:
    fullname: Tomlinson
– volume: 10
  start-page: e0135558
  issue: 8
  year: 2015
  article-title: Analgesic inflammatory properties of gelsolin in acetic acid induced writhing, tail immersion and carrageenan induced paw edema in mice
  publication-title: PLoS One
  contributor:
    fullname: Sagar
– volume: 9
  start-page: R53
  issue: 3
  year: 2007
  article-title: Expression of nitric oxide synthase isoforms in the dorsal horn of monoarthritic rats: Effects of competitive and uncompetitive N-methyl-D-aspartate antagonists
  publication-title: Arthritis Res Ther
  contributor:
    fullname: Pelissier
– volume: 27
  start-page: 121
  issue: 1
  year: 2019
  end-page: 128
  article-title: Preventive treatment with dizocilpine attenuates oedema in a carrageenan model of inflammation: The interaction of glutamatergic and nitrergic signaling
  publication-title: Inflammopharmacology
  contributor:
    fullname: Prostran
– volume: 350
  start-page: 361
  issue: 4
  year: 1994
  end-page: 364
  article-title: Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin
  publication-title: Naunyn-Schmiedeberg’s Arch Pharmacol
  contributor:
    fullname: Muraki
– volume: 20
  start-page: 15593258221103846
  issue: 2
  year: 2022
  article-title: Effect of diclofenac and andrographolide combination on carrageenan-induced paw edema and hyperalgesia in rats
  publication-title: Dose Response
  contributor:
    fullname: Woode
– volume: 9
  start-page: 177
  issue: 2
  year: 1979
  end-page: 183
  article-title: A comparison of the carrageenan edema test and ultraviolet light-induced erythema test as predictors of the clinical dose in rheumatoid arthritis
  publication-title: Agents Actions
  contributor:
    fullname: Gans
– volume: 53
  start-page: 1621
  issue: 11
  year: 2015
  end-page: 1627
  article-title: The antinociceptive effects of magnesium sulfate and MK-801 in visceral inflammatory pain model: The role of NO/cGMP/K(+)ATP pathway
  publication-title: Pharm Biol
  contributor:
    fullname: Prostran
– volume: 105
  start-page: 31
  issue: 1
  year: 2011
  end-page: 43
  article-title: α-Lipoic acid has anti-inflammatory and anti-oxidative properties: An experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations
  publication-title: Br J Nutr
  contributor:
    fullname: Aygun
– volume: 72
  start-page: 1247
  issue: 11
  year: 2003
  end-page: 1257
  article-title: Magnesium-deficient medium enhances NO production in alveolar macrophages isolated from rats
  publication-title: Life Sci
  contributor:
    fullname: Nishio
– volume: 9
  start-page: 923282
  year: 2022
  article-title: Reduced serum magnesium is associated with the occurrence of diabetic macular edema in patients with diabetic retinopathy: A retrospective study
  publication-title: Front Med
  contributor:
    fullname: Yan
– volume: 420
  start-page: 846
  issue: 6917
  year: 2002
  end-page: 852
  article-title: Points of control in inflammation
  publication-title: Nature
  contributor:
    fullname: Nathan
– volume: 450
  start-page: 153
  issue: 2
  year: 2002
  end-page: 162
  article-title: Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Reid
– volume: 7
  start-page: 1293
  issue: 13
  year: 1993
  end-page: 1299
  article-title: Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells
  publication-title: FASEB J
  contributor:
    fullname: Gaboury
– volume: 24
  start-page: 424
  issue: 4
  year: 2017
  end-page: 434
  article-title: Magnesium in pain research: State of the art
  publication-title: Curr Med Chem
  contributor:
    fullname: Prostran
– volume: 14
  start-page: 679
  issue: 3
  year: 2022
  article-title: Effect of magnesium supplementation on inflammatory parameters: A meta-analysis of randomized controlled trials
  publication-title: Nutrients
  contributor:
    fullname: Barbagallo
– volume: 4
  start-page: e16316
  issue: 3
  year: 2014
  article-title: Acute effect of intravenous administration of magnesium sulfate on serum levels of interleukin-6 and tumor necrosis factor-α in patients undergoing elective coronary bypass graft with cardiopulmonary bypass
  publication-title: Anesth Pain Med
  contributor:
    fullname: Dabbagh
– volume: 339
  start-page: 1
  year: 2016
  end-page: 11
  article-title: Participation of peripheral TRPV1, TRPV4, TRPA1 and ASIC in a magnesium sulfate-induced local pain model in rat
  publication-title: Neuroscience
  contributor:
    fullname: Prostran
– volume: 467
  start-page: 111
  issue: 1-3
  year: 2003
  end-page: 118
  article-title: Peripheral tackykinin and excitatory amino acid receptors mediate hyperalgesia induced by Phoneutria nigriventer venom
  publication-title: Eur J Pharmacol
  contributor:
    fullname: Cury
– volume: 27
  start-page: 77
  issue: 2
  year: 2014
  end-page: 85
  article-title: Anti-hyperalgesic effect of systemic magnesium sulfate in carrageenan-induced inflammatory pain in rats: Influence of the nitric oxide pathway
  publication-title: Magnes Res
  contributor:
    fullname: Prostran
– volume: 834
  start-page: 54
  year: 2018
  end-page: 64
  article-title: Evaluation of the antinociceptive and anti-inflammatory activities of piperic acid: Involvement of the cholinergic and vanilloid systems
  publication-title: Eur J Pharmacol
  contributor:
    fullname: de Oliveira
– volume: 20
  start-page: 100
  issue: 2
  year: 2007
  end-page: 106
  article-title: Magnesium ions and ionic channels: Activation, inhibition or block—a hypothesis
  publication-title: Magnes Res
  contributor:
    fullname: Bara
– volume: 44
  start-page: 897
  issue: 6
  year: 2004
  end-page: 902
  article-title: Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endings
  publication-title: Hypertension
  contributor:
    fullname: Fujita
– volume: 42
  start-page: 392
  issue: 3
  year: 1971
  end-page: 402
  article-title: Mediators of the inflammation induced in the rat paw by carrageenin
  publication-title: Br J Pharmacol
  contributor:
    fullname: Meacock
– ident: bibr22-15593258231155788
  doi: 10.1371/journal.pone.0135558
– volume: 20
  start-page: 100
  issue: 2
  year: 2007
  ident: bibr12-15593258231155788
  publication-title: Magnes Res
  contributor:
    fullname: Guiet-Bara A
– ident: bibr30-15593258231155788
  doi: 10.1096/fasebj.7.13.8405815
– ident: bibr37-15593258231155788
  doi: 10.1016/j.ejphar.2018.07.022
– ident: bibr4-15593258231155788
  doi: 10.1684/mrh.2014.0364
– ident: bibr29-15593258231155788
  doi: 10.1007/s10787-017-0361-0
– ident: bibr36-15593258231155788
  doi: 10.1016/j.neuroscience.2016.09.032
– ident: bibr26-15593258231155788
  doi: 10.1016/S0006-8993(01)03240-1
– ident: bibr17-15593258231155788
  doi: 10.1007/BF02024731
– ident: bibr35-15593258231155788
  doi: 10.1038/srep00380
– ident: bibr15-15593258231155788
  doi: 10.1007/BF00178952
– ident: bibr20-15593258231155788
  doi: 10.1016/S0024-3205(02)02371-8
– ident: bibr16-15593258231155788
  doi: 10.1007/s10787-018-0526-5
– ident: bibr21-15593258231155788
  doi: 10.5812/aapm.16316
– ident: bibr8-15593258231155788
  doi: 10.1007/s11011-019-00419-y
– volume: 225
  start-page: 115
  year: 2003
  ident: bibr18-15593258231155788
  publication-title: Methods Mol Biol
  contributor:
    fullname: Morris C
– ident: bibr10-15593258231155788
  doi: 10.1248/bpb.30.1934
– ident: bibr2-15593258231155788
  doi: 10.1177/15593258221103846
– ident: bibr23-15593258231155788
  doi: 10.1111/j.1476-5381.1971.tb07124.x
– ident: bibr14-15593258231155788
  doi: 10.3389/neuro.01.024.2009
– ident: bibr31-15593258231155788
  doi: 10.1007/BF01993127
– ident: bibr28-15593258231155788
  doi: 10.1016/S0014-2999(03)01604-2
– ident: bibr5-15593258231155788
  doi: 10.3109/13880209.2014.996821
– ident: bibr1-15593258231155788
  doi: 10.1038/nature01320
– ident: bibr11-15593258231155788
  doi: 10.1161/01.HYP.0000146536.68208.84
– ident: bibr34-15593258231155788
  doi: 10.4049/jimmunol.166.2.1169
– ident: bibr13-15593258231155788
  doi: 10.3390/nu14030679
– ident: bibr24-15593258231155788
  doi: 10.1016/S0006-8993(01)02733-0
– ident: bibr33-15593258231155788
  doi: 10.1016/j.physbeh.2014.11.042
– ident: bibr6-15593258231155788
  doi: 10.2174/0929867323666161213101744
– ident: bibr9-15593258231155788
  doi: 10.3389/fmed.2022.923282
– ident: bibr32-15593258231155788
  doi: 10.1186/ar2208
– ident: bibr3-15593258231155788
  doi: 10.1016/j.abb.2006.03.031
– ident: bibr25-15593258231155788
  doi: 10.1017/S0007114510003107
– ident: bibr7-15593258231155788
  doi: 10.1016/j.pharep.2017.08.005
– ident: bibr19-15593258231155788
  doi: 10.1016/0304-3959(95)00113-1
– ident: bibr27-15593258231155788
  doi: 10.1016/S0014-2999(02)02119-2
SSID ssj0045731
Score 2.342746
Snippet Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS)...
Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS) in...
Background Magnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS)...
BackgroundMagnesium is an antagonist of the N-methyl-D-aspartate receptor. This study aimed to investigate the anti-edematous effect of magnesium sulfate (MS)...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
sage
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 15593258231155788
SubjectTerms Drug dosages
Edema
Nitric oxide
Special Collection: Inflammatory Parameters as Early Biomarkers in Prediction and Monitoring of Therapeutic Effects in Preclinical and Clinical Studies
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA96T4KI31ZPiSAIQrH5apJHPfc4HzyPOxXfSrYz0YLbk90t-uc7abp7Lqf44lvphDLMTOYjk_6GsWd164VxlS5la7HUIOvSg1IlxNY7A4gSUqF4dGaPP7s3swSTsx31le6EZXjgLLiXsm6DorIgoGh1a42voqeQE6BWQtYxe9_KbYqp7IO1sUpMPcwEr5R6b0qa1PKiRzuOWbmIQiNY_58yzMsXJX-77TUGoMOb7MaUOfJXmeNb7Ar2t9n1fOzG899Edxi8C1_IeXXDgp8N3yIlkvw0gbPiih-E5ZI-i33oyzSwo0Xgp2HNT8IP_raPZBmLsePOZ4CLwD91gR93Cb-fv__ZAfKTjA1LerzLPh7OPhwcldMghbI1Sq7JocGIa2ajrLS1cx21VxUAxNqgtxGk9V6jMCG0lQekmkMrRKypmPFAGdU9ttef9_iA8blAR_7R--iFxhjmmlIWBwIjKhucK9iLjWCb7xkvoxETpPglLRTsdRL9dmGCuh5fkAE0kwE0_zKAgu1vFNdM-2_VJFhEp4Q2RH66JdPOSe2Q0OP5kNYk5B3KqHzB7mc9bzlRVEdR4kIUu2MBO6zuUvru64jOTeE9tbcL9jzZygVLf5XCw_8hhUfsmqT0Kx8O7bO99XLAx-zqCoYn4874BfvmDVI
  priority: 102
  providerName: Directory of Open Access Journals
Title Magnesium Sulfate Reduces Carrageenan-Induced Rat Paw Inflammatory Edema Via Nitric Oxide Production
URI https://journals.sagepub.com/doi/full/10.1177/15593258231155788
https://www.ncbi.nlm.nih.gov/pubmed/36756149
https://www.proquest.com/docview/2792831452
https://search.proquest.com/docview/2774897419
https://pubmed.ncbi.nlm.nih.gov/PMC9900672
https://doaj.org/article/26ca3828ae1c4c7590f9521ad63126f2
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfonpAQ4pvAmIyEhISUtf5IHD9C6TQeNqoNEG-Ra59HpCWd2kbbn8_ZSTqqwQtvUWwlJ9_5_Dvf-WdC3uVWs6yYyJRbBal0PE-1EyJ13uoicwDchUDx-Fyd_iw-zwJNTjachYlF-3ZRHTaX9WFT_Yq1lVe1HQ91YuP5yRQ9aMggjkdkhNhwCNE79yszJVifvgzMSiHtJngWsl34qOINK7cLUOTp_xu4vFsj-UehV1x7jh6Rhz1opB874R6Te9A8IQ-6HTfaHSR6StyJuUC_VbU1PW8vPWJIehZ4WWFNp2a1ws9CY5o03NVhwdEzs6Fzc02_NB6Noo7JdjpzUBv6ozL0tArU_fTrTeWAzjtaWFThM_L9aPZtepz2dyikNhN8g77MRUoz5flEKrWQXmoxcc75PAOtvONKawksM8ZOtAMMN6QAgBzjGO0QTD0ne82ygZeELhgU6Bq19ppJ8GYhEa0UjoEHoUxRJOTDMLDlVUeVUbKeTfyOFhLyKQz9tmNguY4vlquLstd1yXNrBIaEBpiVFgWaeI1ww7hcMJ57npD9QXFlP_XWZWBELASTGTa_3TbjpAmZENPAsg19AukOgimdkBednreSCAyhELNgi9qxgB1Rd1vQTiMxd2-XCXkfbOVWpH-Owqv__sdrcj9cfN9tBu2Tvc2qhTdktHbtQdxWOIiT4jfclg3D
link.rule.ids 230,315,729,782,786,866,887,2108,27935,27936,53803,53805
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfYeAAJ8T0IDDASEhJS1sR24vgRSqdOrKXaBuItcu3ziLSkU9sI_nzO-eioBi97i3KWcsqdz7_znX8m5F1qVJxkkQiZkRAKy9JQWc5D64zKEgvArE8Ux6dy-iP7PPI0OUl_FqZp2jfz4qC6KA-q4mfTW3lZmkHfJzaYTYYYQX0FcbBDbuN8jXifpLcBWCSSx10B03Mr-cIbZ4mvd-GjbO5YuVqCGqb-f8HL612Sf7V6NavP4YMb6v2Q3O_gJv3Yih-RW1A9JvfavTraHkF6QuxEn2PEK-qSntYXDtEnPfGMrrCiQ71cojpQ6Sr0t3wYsPREr-lM_6JHlUN3KpsyPR1ZKDX9Xmg6LTzpP_36u7BAZy2hLBr_Kfl2ODobjsPu9oXQJJytMQrahgxNOhYJKefCCcUja61LE1DSWSaVEhAnWptIWcBERXAASDEDUhZh2B7ZrRYVPCd0HkOGQVUpp2IBTs8F4pzMxuCAS51lAfnQGyS_bEk28rjjIb9mvYB88ibbDPT82M2LxfI87_52zlKjOSaTGmIjDCoUOYVARduUxyx1LCD7vcHzbtKucs-lmPFYJCh-uxHjdPM1FF3BovZjPF0PwjAVkGetf2w04Zh8IdpBidzynC1VtyXoKQ2ld-cZAXnvfexKpf_-hRc3_sYbcmd8NjnOj4-mX16SuwxBW7ultE9218saXpGdla1fN1PqD3ZkIlo
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYkBASGt8sMMBISEhIWeOPxPEjdK02wUq1AeItcu3ziLSkVT8Efz7nJO2oBi_wFuUs5WSfz7_zXX5HyOvMapbmiYy5VRBLx7NYOyFi563OUwfAXQgUj8_V6Ft-NAg0OZtWX03Rvp2Uh_VldViX35vayllle-s6sd74tI8eNGQQezPnezvkJu7ZJF0H6q0TlqkSrEtiBn6lkHwTPA05L3xUTZ-Vq2OoYev_E8S8Xin5W7lXcwIN7_6H7vfIXgc76bt2yH1yA-oH5E57Z0fbX5EeEndqLtDzlauKnq8uPaJQehaYXWFB-2Y-R5WgNnUcun1YcPTMLOnY_KAntUezqpp0PR04qAz9Who6KgP5P_30s3RAxy2xLBrBI_JlOPjcP467LgyxTQVfojd0DSma8jyRSk2kl1okzjmfpaCVd1xpLYGlxthEO8CARQoAyDAS0g7h2GOyW09r2Cd0wiBH56q110yCNxOJeCd3DDwIZfI8Im_Xi1LMWrKNgnV85NdWMCLvw7JtBgae7ObFdH5RdDNe8MwagUGlAWalRYUSrxGwGJcJxjPPI3KwXvSi27yLInAq5oLJFMWvNmLcdiGXYmqYrsKYQNuDcExH5ElrIxtNBAZhiHpQorasZ0vVbQlaS0Pt3VlHRN4EO7tS6a-z8PSfv_GS3BofDYuPJ6MPz8htjtitvVk6ILvL-Qqek52FW71odtUvsUok2g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Magnesium+Sulfate+Reduces+Carrageenan-Induced+Rat+Paw+Inflammatory+Edema+Via+Nitric+Oxide+Production&rft.jtitle=Dose-response&rft.au=Srebro+Dragana&rft.au=Do%C5%BEi%C4%87+Branko&rft.au=Savi%C4%87%2C+Vujovi%C4%87+Katarina&rft.au=Branislava%2C+Medi%C4%87+Brki%C4%87&rft.date=2023-01-01&rft.pub=SAGE+PUBLICATIONS%2C+INC&rft.eissn=1559-3258&rft.volume=21&rft.issue=1&rft_id=info:doi/10.1177%2F15593258231155788
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1559-3258&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1559-3258&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1559-3258&client=summon